Patents by Inventor Gennaro Pagano

Gennaro Pagano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220315651
    Abstract: The invention provides a method of treating, preventing or ameliorating Parkinson's disease with Prasinezumab.
    Type: Application
    Filed: March 8, 2022
    Publication date: October 6, 2022
    Inventor: Gennaro PAGANO
  • Publication number: 20220098291
    Abstract: The invention provides a method of treating, preventing or ameliorating Parkinson's disease with Prasinezumab.
    Type: Application
    Filed: September 10, 2021
    Publication date: March 31, 2022
    Inventors: Gennaro PAGANO, Wagner ZAGO
  • Patent number: 10632124
    Abstract: The present disclosure teaches methods for treating and preventing a variety of neurodegenerative conditions and symptoms associated therewith, including Alzheimer's disease (AD) and idiopathic Parkinson's disease (iPD), by utilizing adrenoceptor antagonists. Adrenoceptor antagonists that can be used include ?-blockers, such as acebutolol, betaxolol, bisopropolol, bopindolol, carvedilol, metoprolol, oxprenolol, propranolol, and timolol. The present disclosure also teaches methods for diagnosing and monitoring the progression of iPD.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: April 28, 2020
    Assignee: Cedars-Sinai Medical Center
    Inventors: Michele Tagliati, Gennaro Pagano
  • Publication number: 20190083507
    Abstract: The present disclosure teaches methods for treating and preventing a variety of neurodegenerative conditions and symptoms associated therewith, including Alzheimer's disease (AD) and idiopathic Parkinson's disease (iPD), by utilizing adrenoceptor antagonists. Adrenoceptor antagonists that can be used include ?-blockers, such as acebutolol, betaxolol, bisopropolol, bopindolol, carvedilol, metoprolol, oxprenolol, propranolol, and timolol. The present disclosure also teaches methods for diagnosing and monitoring the progression of iPD.
    Type: Application
    Filed: September 26, 2018
    Publication date: March 21, 2019
    Applicant: Cedars-Sinai Medical Center
    Inventors: Michele Tagliati, Gennaro Pagano
  • Patent number: 10111879
    Abstract: The present disclosure teaches methods for treating and preventing a variety of neurodegenerative conditions and symptoms associated therewith, including Alzheimer's disease (AD) and idiopathic Parkinson's disease (iPD), by utilizing adrenoceptor antagonists. Adrenoceptor antagonists that can be used include ?-blockers, such as acebutolol, betaxolol, bisopropolol, bopindolol, carvedilol, metoprolol, oxprenolol, propranolol, and timolol. The present disclosure also teaches methods for diagnosing and monitoring the progression of iPD.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: October 30, 2018
    Assignee: Cedars-Sinai Medical Center
    Inventors: Michele Tagliati, Gennaro Pagano
  • Publication number: 20160324862
    Abstract: The present invention teaches methods for treating a variety of neurodegenerative conditions, including Alzheimer's disease (AD) and idiopathic Parkinson's disease (iPD), by utilizing adrenoceptor antagonists. Adrenoceptor antagonists that can be used include ?-blockers, such as acebutolol, betaxolol, bisopropolol, bopindolol, carvedilol, metoprolol, oxprenolol, propranolol, and timolol.
    Type: Application
    Filed: June 27, 2014
    Publication date: November 10, 2016
    Inventors: Michele Tagliati, Gennaro Pagano